1-9 of 9
neurotoxicity syndromes
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Fatal late-onset CAR T-cell–mediated encephalitis after axicabtagene-ciloleucel in a patient with large B-cell lymphoma

Clinical Trials & Observations
Susanne Jung, Jochen Greiner, Stephanie von Harsdorf, Pavle Popovic, Roland Moll, Jens Schittenhelm, Kosmas Kandilaris, Volker Daniel, Alexander Kunz, Michael Schmitt, Peter Dreger
Journal: Blood Advances
Blood Adv (2021) 5 (19): 3789–3793.
https://doi.org/10.1182/bloodadvances.2021004889
Published: 2021
Includes: Supplemental data
Journal Articles

Modified EASIX predicts severe cytokine release syndrome and neurotoxicity after chimeric antigen receptor T cells

Clinical Trials & Observations
Martina Pennisi, Miriam Sanchez-Escamilla, Jessica R. Flynn, Roni Shouval, Ana Alarcon Tomas, Mari Lynn Silverberg, Connie Batlevi, Renier J. Brentjens, Parastoo B. Dahi, Sean M. Devlin, Claudia Diamonte, Sergio Giralt, Elizabeth F. Halton, Tania Jain, Molly Maloy, Elena Mead, Maria Lia Palomba, Josel Ruiz, Bianca Santomasso, Craig S. Sauter, Michael Scordo, Gunjan L. Shah, Jae H. Park, Lucrecia Yanez San Segundo, Miguel-Angel Perales
Journal: Blood Advances
Blood Adv (2021) 5 (17): 3397–3406.
https://doi.org/10.1182/bloodadvances.2020003885
Published: 2021
Includes: Supplemental data
Journal Articles

CRP and ferritin in addition to the EASIX score predict CAR-T–related toxicity

Clinical Trials & Observations
Uri Greenbaum, Paolo Strati, Rima M. Saliba, Janet Torres, Gabriela Rondon, Yago Nieto, Chitra Hosing, Samer A. Srour, Jason Westin, Luis E. Fayad, Hun J. Lee, Swaminathan P. Iyer, Ranjit Nair, Loretta J. Nastoupil, Simrit Parmar, Maria A. Rodriguez, Felipe Samaniego, Raphael E. Steiner, Michael Wang, Chelsea C. Pinnix, Christopher R. Flowers, Sudhakar Tummala, Jeremy L. Ramdial, Fevzi F. Yalniz, Misha Hawkins, Katayoun Rezvani, Richard E. Champlin, Elizabeth J. Shpall, Sattva S. Neelapu, Partow Kebriaei, Sairah Ahmed
Journal: Blood Advances
Blood Adv (2021) 5 (14): 2799–2806.
https://doi.org/10.1182/bloodadvances.2021004575
Published: 2021
Includes: Supplemental data
Journal Articles

Clinical and radiologic correlates of neurotoxicity after axicabtagene ciloleucel in large B-cell lymphoma

Clinical Trials & Observations
Paolo Strati, Loretta J. Nastoupil, Jason Westin, Luis E. Fayad, Sairah Ahmed, Nathan H. Fowler, Fredrick B. Hagemeister, Hun J. Lee, Swaminathan P. Iyer, Ranjit Nair, Simrit Parmar, Maria A. Rodriguez, Felipe Samaniego, Raphael E. Steiner, Michael Wang, Chelsea C. Pinnix, Sherry Adkins, Catherine M. Claussen, Charles S. Martinez, Misha C. Hawkins, Nicole A. Johnson, Prachee Singh, Haleigh E. Mistry, Sandra Horowitz, Shirley George, Lei Feng, Partow Kebriaei, Elizabeth J. Shpall, Sattva S. Neelapu, Sudhakar Tummala, T. Linda Chi
Journal: Blood Advances
Blood Adv (2020) 4 (16): 3943–3951.
https://doi.org/10.1182/bloodadvances.2020002228
Published: 2020
Journal Articles

Efficacy and safety of anti-CD19 CAR T-cell therapy in 110 patients with B-cell acute lymphoblastic leukemia with high-risk features

Clinical Trials & Observations
Xian Zhang, Xin-an Lu, Junfang Yang, Gailing Zhang, Jingjing Li, Lisong Song, Yunchao Su, Yanze Shi, Min Zhang, Jiujiang He, Dan Song, Fanyong Lv, Wenqian Li, Yan Wu, Hui Wang, Hongxing Liu, Xiaosu Zhou, Ting He, Peihua Lu
Journal: Blood Advances
Blood Adv (2020) 4 (10): 2325–2338.
https://doi.org/10.1182/bloodadvances.2020001466
Published: 2020
Includes: Supplemental data
Journal Articles

Intrathecal chemotherapy for management of steroid-refractory CAR T-cell–associated neurotoxicity syndrome

Clinical Trials & Observations
Nirav N. Shah, Bryon D. Johnson, Timothy S. Fenske, Renju V. Raj, Parameswaran Hari
Journal: Blood Advances
Blood Adv (2020) 4 (10): 2119–2122.
https://doi.org/10.1182/bloodadvances.2020001626
Published: 2020
Journal Articles

Grading of neurological toxicity in patients treated with tisagenlecleucel in the JULIET trial

Clinical Trials & Observations
Richard T. Maziarz, Stephen J. Schuster, Vadim V. Romanov, Elisha S. Rusch, Junlong Li, James E. Signorovitch, David G. Maloney, Frederick L. Locke
Journal: Blood Advances
Blood Adv (2020) 4 (7): 1440–1447.
https://doi.org/10.1182/bloodadvances.2019001305
Published: 2020
Includes: Supplemental data
Journal Articles

CAR T-cell therapy: is it prime time in myeloma?

Surbhi Sidana, Nina Shah
Journal: Blood Advances
Blood Adv (2019) 3 (21): 3473–3480.
https://doi.org/10.1182/bloodadvances.2019000370
Published: 2019
Journal Articles

No free rides: management of toxicities of novel immunotherapies in ALL, including financial

Clinical Trials & Observations
Tania Jain, Mark R. Litzow
Journal: Blood Advances
Blood Adv (2018) 2 (22): 3393–3403.
https://doi.org/10.1182/bloodadvances.2018020198
Published: 2018